/RBRXF

RBRXF Stock - Rhino Biotech Limited

Q: What is the analyst price target for RBRXF?

Analyst price target information is not currently available for RBRXF.

Q: What is RBRXF's market cap?

Market capitalization information is not currently available for RBRXF.

Financial Services|Shell Companies|OTC

$0.00+9900.00%

+$0.00 (+9900.00%) • Mar 6

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for RBRXF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2016

FY2017

FY2018

FY2019

FY2020

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-0.19

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2020	FY2019	FY2018	FY2017	FY2016
Revenue	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A
Gross Margin	N/A	N/A	N/A	N/A	N/A
Operating Income	$-21,233	$-20,420	$-13,870	$-22,840	$-24,400
Net Income	$-21,233	$-20,423	$-13,872	$-22,837	$-24,401
Net Margin	N/A	N/A	N/A	N/A	N/A
EPS	$-0.00	$-0.00	$-0.00	$-0.00	$-0.00

Company Overview

Rhino Biotech Limited intends to develop plant and fungi derived nutraceuticals, and preventative and curative biopharmaceuticals. The company was formerly known as Eurasia Energy Limited and changed its name to Rhino Biotech Limited in September 2021. Rhino Biotech Limited was incorporated in 2003 and is based in South Hill, Anguilla.

Visit Website

Frequently Asked Questions about RBRXF

What is RBRXF's current stock price?

Rhino Biotech Limited (RBRXF) is currently trading at $0.00 per share. The stock has moved +9900.00% today.

What is the analyst price target for RBRXF?

No analyst price targets are currently available for this stock.

What sector is Rhino Biotech Limited in?

Rhino Biotech Limited operates in the Financial Services sector, specifically within the Shell Companies industry. The company is traded on the OTC exchange.

What is RBRXF's market cap?

Rhino Biotech Limited has a market capitalization of $0.00 billion, making it a small-cap company.

Does RBRXF pay dividends?

No, Rhino Biotech Limited does not currently pay a dividend to shareholders.